Time

Event

8:00 am – Lobby Level

Registration Opens

8:00 am – Ground Floor,
Event Hall South

One-to-One Meetings 

8:55 am – 2nd Floor

Welcome Back 

• Sara Jane Demy, Founder & CEO, Demy-Colton

9:00 am – 2nd Floor

“Big Think" Plenary Session  

The New Policy Landscape: How it’s Benefiting the Sector

Moderator:

• Yeji Jesse Lee, Senior Healthcare Reporter, Law360

Panel: 

• Jennifer Hawks Bland, CEO, NewYorkBIO
• Cartier Esham, CEO, Esham Strategies
• Nancy Myers, CEO & Founder, Catalyst Healthcare Consulting 
• Peter Rubin, Executive Director, No Patient Left Behind 

10:00 am – Ground Floor,
Event Hall South

One-to-One Meetings

10:00 am – 2nd Floor

Dialogue 4A 

AI: From Target and Lead Discovery to Clinical Trials and Personalized Medicine – Revolutionizing Drug Development 

Moderator:

• Rachel Ravens, Co-Founder & Managing Partner, 46Health

Panel: 

• Martin Akerman, CTO, Co-founder, Envisagenics, Inc.
• Ahmet-Hamdi Çavuşoğlu, Senior Director, Merck Digital Sciences Studio
• Vitalay Fomin, Co-Founder & CEO, Numenos

11:00 am – 2nd Floor

Seed Pitch Doctor Presentations 

Moderator:

• Jay Campbell, Life Sciences Executive, CBO, CFO, & Advisory Board Member 

Pitch Doctors:

• Jessica Federer, Investor & Board Member, Angelini Ventures
• Michael Langer, Co-Founder & Managing Partner, T.Rx Capital
• Stacey Seltzer, Managing Partner & Founder, Pontiva Healthcare Partners

Seed Companies:

• Aetherium Bio
• Chiara Biosciences, Inc
• Kalm Therapeutics
• Neutargeton Therapeutics
• Niche Biopharmaceuticals, LLC
• Tidewave Bio

12:15 pm – Ground Floor,
Event Hall South

Lunch

1:15 pm – 2nd Floor

“Big Think” Plenary Session 

Venture Investment in Early-Stage Biopharma: Are We Seeing Signs of Recovery?

Moderator:

• Kelliann Payne, Partner, Global Regulatory, Hogan Lovells

Panel:

• Jessica Federer, Investor & Board Member, Angelini Ventures
• Claire Jin, VP, Startup Banking Life Sciences and Healthcare, J.P. Morgan
• Michael Langer, Co-Founder & Managing Partner, T.Rx Capital
• Wonhee Oh, VP, Healthcare Investment Banking, J.P. Morgan

2:15 pm – 2nd Floor

Closing “Big Think” Plenary Session 

Heard Around the Street: What’s Buzzing in Biopharma       

Moderator:  

• Virginia Amann, CEO & Founder, ENTENTE Networks 

Panel:

• Max Bayer, Pharma Reporter, Endpoints News
• Yeji Jesse Lee, Senior Healthcare Reporter, Law360
• Alex Philippidis, Senior Business Editor, Genetic Engineering & Biotechnology News (GEN)
• Aayushi Pratap, Associate Editor, C&EN, American Chemical Society